Penel N - Search Results

1

Nomogram to predict treatment outcome of fluoropyrimidine/platinum-based chemotherapy in metastatic esophageal squamous cell carcinoma.

Jung HA, Adenis A, Lee J, Park SH, Maeng CH, Park S, Ahn HK, Shim YM, Penel N, Im YH. Jung HA, et al. Among authors: penel n. Cancer Res Treat. 2013 Dec;45(4):285-94. doi: 10.4143/crt.2013.45.4.285. Epub 2013 Dec 31. Cancer Res Treat. 2013. PMID: 24454001 Free PMC article.

2

Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis.

Penel N, Dewas S, Doutrelant P, Clisant S, Yazdanpanah Y, Adenis A. Penel N, et al. Support Care Cancer. 2008 Apr;16(4):387-92. doi: 10.1007/s00520-007-0322-z. Epub 2007 Aug 21. Support Care Cancer. 2008. PMID: 17710443

3

Angiosarcomas and taxanes.

Penel N, Lansiaux A, Adenis A. Penel N, et al. Curr Treat Options Oncol. 2007 Dec;8(6):428-34. doi: 10.1007/s11864-007-0042-0. Epub 2007 Dec 8. Curr Treat Options Oncol. 2007. PMID: 18066504 Review.

4

[Methodological approaches of clinical studies with targeted therapies].

Penel N, Saleron J, Lansiaux A, Clisant S, Adenis A, Fournier C, Duhamel A, Bonneterre J. Penel N, et al. Bull Cancer. 2008 Feb;95(2):185-90. doi: 10.1684/bdc.2008.0575. Bull Cancer. 2008. PMID: 18304903 Review. French.

5

Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases.

Penel N, Grosjean J, Robin YM, Vanseymortier L, Clisant S, Adenis A. Penel N, et al. Sarcoma. 2008;2008:459386. doi: 10.1155/2008/459386. Sarcoma. 2008. PMID: 18497869 Free PMC article.

6

Imatinib as a possible cause of severe rhabdomyolysis.

Penel N, Blay JY, Adenis A. Penel N, et al. N Engl J Med. 2008 Jun 19;358(25):2746-7. doi: 10.1056/NEJMc0708896. N Engl J Med. 2008. PMID: 18565874 No abstract available.

7

Publication biases and phase II trials investigating anticancer targeted therapies.

Penel N, Adenis A. Penel N, et al. Invest New Drugs. 2009 Jun;27(3):287-8. doi: 10.1007/s10637-008-9186-4. Epub 2008 Oct 18. Invest New Drugs. 2009. PMID: 18931825

8

Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics.

Penel N, Delord JP, Bonneterre ME, Bachelot T, Ray-Coquard I, Blay JY, Pascal LB, Borel C, Filleron T, Adenis A, Bonneterre J. Penel N, et al. Invest New Drugs. 2010 Feb;28(1):76-82. doi: 10.1007/s10637-009-9224-x. Epub 2009 Feb 10. Invest New Drugs. 2010. PMID: 19205623

9

Cancer-associated hypercalcemia: validation of a bedside prognostic score.

Penel N, Dewas S, Hoffman A, Adenis A. Penel N, et al. Support Care Cancer. 2009 Aug;17(8):1133-5. doi: 10.1007/s00520-009-0607-5. Epub 2009 Mar 17. Support Care Cancer. 2009. PMID: 19290550

10

Phase II trials in patients with carcinoma of unknown primary: a pooled data analysis.

Adenis A, Ferté C, Penel N. Adenis A, et al. Among authors: penel n. Invest New Drugs. 2010 Apr;28(2):178-84. doi: 10.1007/s10637-009-9261-5. Epub 2009 May 8. Invest New Drugs. 2010. PMID: 19424663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters